Magstim – New FDA Clearance for TMS Treatment in U.S. Adolescent Patients
By Amy Banks
Exciting News in Mental Health Treatment Magstim Horizon Inspire and 3.0 Transcranial Magnetic Stimulation Systems have officially received FDA clearance for the treatment of Major Depressive Disorder (MDD) in adolescent patients, ages 15-21. This marks a significant milestone in mental health care, opening new doors for more effective, non-invasive treatment options tailored specifically for younger … Continued